InvestorsHub Logo
Followers 14
Posts 2307
Boards Moderated 0
Alias Born 01/02/2003

Re: None

Saturday, 03/13/2021 8:59:54 AM

Saturday, March 13, 2021 8:59:54 AM

Post# of 463629
Pretty soon Anavex would/should put out a PR like this about memory improvement in PDD patients. This is a great accomplishment that went unnoticed (or didn’t get enough coverage) on wallstreet.

Eli Lilly’s drug could slow cognitive decline.....which means that memory stayed at the same point during the trials as opposed to the placebo group....whereas Anavex’s drug not only slowed but also reversed the cognitive decline. This should put it in the right perspective for the scientific community and wallstreet with patients gaining ultimately.

Eli’s announcement
https://finance.yahoo.com/news/lilly-alzheimers-drug-shows-benefit-114314048.html

Anavex’s recent slides have the details on the PDD improvements.

-vg_future
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News